A detailed history of Beaird Harris Wealth Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Beaird Harris Wealth Management, LLC holds 427 shares of BMY stock, worth $24,586. This represents 0.0% of its overall portfolio holdings.

Number of Shares
427
Previous 1,020 58.14%
Holding current value
$24,586
Previous $42,000 47.62%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 02, 2024

SELL
$39.66 - $51.75 $23,518 - $30,687
-593 Reduced 58.14%
427 $22,000
Q2 2024

Aug 15, 2024

BUY
$40.25 - $52.99 $201 - $264
5 Added 0.49%
1,020 $42,000
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $191 - $217
4 Added 0.4%
1,015 $55,000
Q4 2023

Feb 27, 2024

BUY
$48.48 - $57.85 $145 - $173
3 Added 0.3%
1,011 $51,000
Q3 2023

Nov 15, 2023

BUY
$57.89 - $64.73 $173 - $194
3 Added 0.3%
1,008 $58,000
Q2 2023

Jul 26, 2023

BUY
$63.71 - $70.74 $191 - $212
3 Added 0.3%
1,005 $64,000
Q1 2023

Apr 24, 2023

SELL
$65.71 - $74.53 $7,950 - $9,018
-121 Reduced 10.77%
1,002 $69,000
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $5,136 - $6,081
-75 Reduced 6.26%
1,123 $80,000
Q3 2022

Nov 02, 2022

BUY
$0.13 - $76.84 $77 - $46,027
599 Added 100.0%
1,198 $85,000
Q2 2022

Aug 12, 2022

SELL
$72.62 - $79.98 $43,136 - $47,508
-594 Reduced 49.79%
599 $46,000
Q1 2022

May 27, 2022

BUY
$61.48 - $73.72 $122 - $147
2 Added 0.17%
1,193 $87,000
Q4 2021

May 17, 2022

BUY
$53.63 - $62.52 $63,873 - $74,461
1,191 New
1,191 $74,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Beaird Harris Wealth Management, LLC Portfolio

Follow Beaird Harris Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaird Harris Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beaird Harris Wealth Management, LLC with notifications on news.